Last updated on November 2018

A Phase 1/2 Study of INCB053914 in Subjects With Advanced Malignancies


Brief description of study

The purpose of this Study is to evaluate the safety and tolerability of INCB053914 alone and in combination with standard therapies in subjects that have advanced cancer.

Clinical Study Identifier: TX203805

Find a site near you

Start Over

MAYO CLINIC FLORIDA

Located in: Jacksonville, FL USA
  Connect »

UCLA MEDICAL HEMATOLOGY & ONCOLOGY

Located in: Los Angeles, CA USA
  Connect »

DANA-FARBER CANCER INSTITUTE

Located in: Boston, MA USA
  Connect »

TENNESSEE ONCOLOGY

Located in: Nashville, TN USA
  Connect »

FLORIDA CANCER SPECIALISTS

Located in: Sarasota, FL USA
  Connect »

YALE UNIVERSITY

Located in: New Haven, CT USA
  Connect »

STEPHENSON CANCER CENTER

Located in: Oklahoma City, OK USA
  Connect »

TEXAS ONCOLOGY - TYLER

Located in: Tyler, TX USA
  Connect »

TEXAS ONCOLOGY

Located in: Austin, TX USA
  Connect »

MEDICAL COLLEGE OF WISCONSIN

Located in: Milwaukee, WI USA
  Connect »

MOFFITT CANCER CENTER

Located in: Tampa, FL USA
  Connect »